Humira Biosimilar Drug Accepted to Conduct Clinical Trial in UK for Crohn’s, Other Autoimmune Diseases
News
Cambridge, Massachusetts-based biotechnology company, Momenta Pharmaceuticals, Inc., has just announced the UK Medicines and Healthcare Products Regulatory Agency (MHRA) has accepted the company’s Clinical Trial Application (CTA) for a study ... Read more